Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00257673
Status:
COMPLETED
Last Update Posted:
2008-05-06
First Post:
2005-11-22
Brief Title:
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimers Disease
Sponsor:
Memory Pharmaceuticals
Organization:
Memory Pharmaceuticals
Organization Data
Organization:
Memory Pharmaceuticals
Class:
INDUSTRY
Study ID:
MEM 1003-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Memory Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Amy S Domanowski PhD Head Regulatory Affairs
Old Organization:
Memory Pharmaceuticals Corp